BiotechTube
Home/TScan Therapeutics/Ann Hargraves
AH

Ann Hargraves

Senior Vice President, Human Resources

TScan Therapeutics

Therapeutic Areas

OncologyAutoimmune Diseases

TScan Therapeutics Pipeline

DrugIndicationPhase
TSC-101Hematologic malignancies (Acute Myeloid Leukemia, Myelodysplastic Syndromes)Phase 1
TSC-102-A01Hematologic malignanciesPreclinical
TSC-102-A03Hematologic malignanciesPreclinical
Multiple Unnamed TCR-T CandidatesSolid TumorsPreclinical
In Vivo-Engineered T Cell ProgramsNot Specified (Likely Cancer)Preclinical
Autoimmune Disease ProgramsAutoimmune DisordersDiscovery

Leadership Team at TScan Therapeutics

GM
Gavin MacBeath
Chief Executive Officer
JA
Jason Amello
Chief Financial Officer and Treasurer
CL
Chrystal Louis
Chief Medical Officer
ZZ
Zoran Zdraveski
Chief Legal and Strategy Officer and Secretary
SC
Stephen Camiolo
Senior Vice President, Market Access
SC
Shrikanta Chattopadhyay
Senior Vice President, Head of Translational Medicine
CG
Cagan Gurer
Senior Vice President, Discovery
RL
Ray Lockard
Senior Vice President, Head of Quality
JM
Jim Murray
Senior Vice President, Head of Development Operations
SB
Stephen Biggar
Partner at Baker Bros. Advisors LP (Board of Directors)
View full TScan Therapeutics profile